Why AbCellera Biologics Inc. (ABCL) stock rose 7.5% intraday on Tuesday, November 3, 2026

AbCellera Biologics Inc. (ABCL) traded at $11.95 as of 9:51 AM ET, up 7.46% on Tuesday, November 3, 2026, on volume of 238,574 shares (0.0× its 3-month average); market value about $3.90B.

ABCL was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.

What happened: primary sources

Events Nexqual found for ABCL on Tuesday, November 3, 2026 or the trading day before (November 2, 2026):

• Nov 3, 2026: One of 3 Canada-based companies among the day's biggest gainers (ACB, ABCL, POET)

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on ABCL

ABCL stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 3, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 4, 2026 at 09:48 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 4, 2026 at 09:48 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt